{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:18:20Z","timestamp":1791429500411,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.vaccine.2021.09.032","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T01:05:32Z","timestamp":1633482332000},"page":"6781-6786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Shingles vaccination uptake in Massachusetts adults aged 50 years and older"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8937-9325","authenticated-orcid":false,"given":"Marina","family":"Draper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Stergiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.09.032_b0005","unstructured":"ACIP Presentation Slides: February 2011 Meeting."},{"key":"10.1016\/j.vaccine.2021.09.032_b0010","unstructured":"CDC. Prevention of Herpes Zoster Recommendations of the ACIP. MMWR Early Release 2008;57(2008):1\u201323."},{"issue":"6","key":"10.1016\/j.vaccine.2021.09.032_b0015","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.jaad.2007.09.017","article-title":"Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia","volume":"57","author":"Betts","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2021.09.032_b0020","unstructured":"Shingles VIS, Shingles Vaccine (9\/11\/06)."},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.032_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268803001523","article-title":"Gender Difference in the Incidence of Shingles","volume":"132","author":"Fleming","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"22","key":"10.1016\/j.vaccine.2021.09.032_b0030","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.09.032_b0035","first-page":"729","article-title":"Update on Recommendations for Use of Herpes Zoster Vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2021.09.032_b0040","unstructured":"CDC. Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years. MMWR 2011;60:1528."},{"key":"10.1016\/j.vaccine.2021.09.032_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.09.032_b0050","unstructured":"Healthy People 2020 Objective. IID-14 Increase the percentage of adults who are vaccinated against zoster (shingles)."},{"issue":"6","key":"10.1016\/j.vaccine.2021.09.032_b0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","article-title":"Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors","volume":"27","author":"Lu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.09.032_b0060","unstructured":"Williams W, Lu PJ, O\u2019Halloran A, et al., Vaccination Coverage Among Adults, Excluding Influenza Vaccination \u2014 United States. 2013 MMWR Morbid Mortal Weekly Rep 2015;64:95\u2013102."},{"key":"10.1016\/j.vaccine.2021.09.032_b0065","unstructured":"Schiller JS, Euler GL. Vaccination coverage estimates from the National Health Interview Survey: United States. National Center for Health Statistics; 2008."},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.032_b0070","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amepre.2010.10.012","article-title":"Herpes Zoster Vaccination Among Adults Aged 60 Years and Older, in the U.S., 2008","volume":"40","author":"Lu","year":"2011","journal-title":"Am J Prevent Med"},{"key":"10.1016\/j.vaccine.2021.09.032_b0075","unstructured":"Williams W, Lu P, Singleton J, et al., Adult Vaccination Coverage \u2014 United States, 2010 MMWR 2012;61:66\u201372."},{"key":"10.1016\/j.vaccine.2021.09.032_b0080","unstructured":"CDC. Noninfluenza Vaccination Coverage Among Adults \u2013 United States, 2011. MMWR 2013;62:66\u201372."},{"issue":"3","key":"10.1016\/j.vaccine.2021.09.032_b0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.amepre.2016.08.031","article-title":"National and State-Specific Shingles Vaccination Among Adults Aged >60 Years","volume":"52","author":"Lu","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2021.09.032_b0090","unstructured":"Vaccination Coverage among Adults in the United States, National Health Interview Survey. Herpes Zoster Vaccination; 2017."},{"key":"10.1016\/j.vaccine.2021.09.032_b0100","unstructured":"PCORI. Draft National Priorities for Research and Research Agenda (Version 1); January 23, 2012."},{"key":"10.1016\/j.vaccine.2021.09.032_b0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the Use of Herpes Zoster Vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2021.09.032_b0110","doi-asserted-by":"crossref","unstructured":"Public Health Reports. NVAC: Recommendations for Adult Immunization. A Pathway to Leadership for Adult Immunization: Recommendations of the National Vaccine Advisory Committee 2012;127(Supplement 1).","DOI":"10.1177\/00333549121270S101"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.032_b0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vaccine.2008.10.047","article-title":"Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly","volume":"27","author":"Opstelten","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2021.09.032_b0120","first-page":"A4345","article-title":"Perceptions of herpes zoster and attitudes towards zoster vaccination among 50\u201365-year-old Danes","volume":"58","author":"Mortensen","year":"2011","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.vaccine.2021.09.032_b0125","doi-asserted-by":"crossref","first-page":"e009062","DOI":"10.1136\/bmjopen-2015-009062","article-title":"The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers","volume":"5","author":"MacDougall","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.032_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000240046","article-title":"Public awareness and knowledge of herpes zoster: results of a global survey","volume":"56","author":"Paek","year":"2010","journal-title":"Gerontology"},{"key":"10.1016\/j.vaccine.2021.09.032_b0135","unstructured":"MDPH. Health of Massachusetts. Boston, MA; April 2010."},{"key":"10.1016\/j.vaccine.2021.09.032_b0140","unstructured":"MDPH. A Profile of Health Among Massachusetts Adults, 2014 Results from the Behavioral Risk Factor Surveillance System."},{"key":"10.1016\/j.vaccine.2021.09.032_b0145","unstructured":"The General Court of the Commonwealth of Massachusetts. An Act Providing Access to Affordable, Quality, and Accountable Health Care; St. 2006, c.58."},{"key":"10.1016\/j.vaccine.2021.09.032_b0150","unstructured":"CDC. Selected Articles Related to BRFSS and Other Self-Reported Data; 2021. https:\/\/www.cdc.gov\/brfss\/publications\/mvr.html."},{"key":"10.1016\/j.vaccine.2021.09.032_b0155","unstructured":"CDC. BRFSS Asthma Call-back Survey; 2021. https:\/\/www.cdc.gov\/brfss\/acbs\/."},{"key":"10.1016\/j.vaccine.2021.09.032_b0160","series-title":"Handbook of Mixed Methods in Social & Behavioral Research","author":"Tashakkori","year":"2003"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.032_b0165","first-page":"281","article-title":"A Typology of Mixed Methods Sampling Designs in Social Science Research","volume":"12","author":"Onwuegbuzie","year":"2007","journal-title":"The Qualitative Report"},{"issue":"8","key":"10.1016\/j.vaccine.2021.09.032_b0170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.annepidem.2010.05.006","article-title":"Sample design and cohort selection in the Hispanic Community Health Study\/Study of Latinos","volume":"20","author":"LaVange","year":"2010","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.vaccine.2021.09.032_b0175","series-title":"Focus Groups A Practical Guide for Applied Research","author":"Krueger","year":"2000"},{"key":"10.1016\/j.vaccine.2021.09.032_b0180","unstructured":"Department of Health and Human Services. National Cancer Institute. Theory at a Glance A Guide for Health Promotion Practice, 2nd ed.; 2005."},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.032_b0185","doi-asserted-by":"crossref","first-page":"e1002469","DOI":"10.1371\/journal.pcbi.1002469","article-title":"The Impact of Imitation on Vaccination Behavior in Social Contact Networks","volume":"8","author":"Ndeffo Mbah","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2021.09.032_b0190","unstructured":"GAO. Medicare Many Factors, Including Administrative Challenges, Affect Access to Part D Vaccinations (GAO-12-61); December 2011."},{"key":"10.1016\/j.vaccine.2021.09.032_b0195","unstructured":"Marrufo G, et al. Estimating the Effects of Consolidating Drugs under Part D or Part B (Acumen, LLC, Sept. 2011)."},{"key":"10.1016\/j.vaccine.2021.09.032_b0200","unstructured":"CDC. Adult Vaccine Price List; 2018."},{"key":"10.1016\/j.vaccine.2021.09.032_b0205","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","article-title":"Cost-Effectiveness of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults","volume":"44","author":"Rothberg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.09.032_b0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/M15-0093","article-title":"Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years","volume":"163","author":"Le","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2021.09.032_b0215","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.09.032_b0220","doi-asserted-by":"crossref","DOI":"10.1377\/hlthaff.2016.1088","article-title":"In New Survey of 11 Countries, U.S. Adults Still Struggle with Access to and Affordability of Health Care","author":"Osborn","year":"2016","journal-title":"Health Affairs Web First"},{"issue":"2","key":"10.1016\/j.vaccine.2021.09.032_b0225","first-page":"248","article-title":"Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"178","author":"Le","year":"2018","journal-title":"J Am Med Assoc Int Med"},{"issue":"11","key":"10.1016\/j.vaccine.2021.09.032_b0230","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1377\/hlthaff.2010.0878","article-title":"Applying Value-Based Insurance Design To Low-Value Health Services","volume":"29","author":"Fendrick","year":"2010","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2021.09.032_b0235","unstructured":"CDC. Overview A Series on Standards for Adult Immunization Practice; 2016."},{"key":"10.1016\/j.vaccine.2021.09.032_b0240","doi-asserted-by":"crossref","unstructured":"Guffey Thomas,Yang Philip Q. Trust in Doctors: Are African Americans Less Likely to Trust Their Doctors Than White Americans? SAGE Open. https:\/\/doi.org\/10.1177\/2158244012466092.","DOI":"10.1177\/2158244012466092"},{"issue":"5","key":"10.1016\/j.vaccine.2021.09.032_b0245","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/1475-6773.01070","article-title":"Trust in the Medical Profession: Conceptual and Measurement Issues","volume":"37","author":"Hall","year":"2002","journal-title":"Health Serv Res"},{"issue":"4","key":"10.1016\/j.vaccine.2021.09.032_b0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1377\/hlthaff.23.4.124","article-title":"Gregory Pawlson Measuring Patients' Trust In Physicians When Assessing Quality Of Care","volume":"23","author":"Thom","year":"2004","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2021.09.032_bib281","unstructured":"Healthy People 2030 Objective IID-09 Increase the proportion of people who get the flu vaccine every year \u2014target 70%. Healthy People 2030 2030."},{"issue":"1","key":"10.1016\/j.vaccine.2021.09.032_b0265","first-page":"15","article-title":"Medicare Physician Group Practice Demonstration Design: Quality and Efficiency Pay-for-Performance","volume":"29","author":"Kautter","year":"2007","journal-title":"Health Care Finan Rev"},{"key":"10.1016\/j.vaccine.2021.09.032_b0270","unstructured":"Centers for Disease Control and Prevention. National Adult Immunization Plan (NAIP). Objective 1.5: Evaluate and advance targeted quality improvement initiatives."},{"key":"10.1016\/j.vaccine.2021.09.032_b0275","unstructured":"Department of Health and Human Services Secretary\u2019s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 (Committee) Report #4: Target-Setting Methodologies for Objectives in Healthy People 2030 Final Report, 7\u201323-2018."},{"key":"10.1016\/j.vaccine.2021.09.032_b0280","unstructured":"Pew Research Center, April 2014, \u201cOlder Adults and Technology Use\u201d."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21012238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:03:20Z","timestamp":1759403000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21012238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0264410X21012238"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shingles vaccination uptake in Massachusetts adults aged 50 years and older","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}